scispace - formally typeset
S

Shigeo Nakamura

Researcher at Nippon Medical School

Publications -  115
Citations -  2266

Shigeo Nakamura is an academic researcher from Nippon Medical School. The author has contributed to research in topics: Copolymer & Monomer. The author has an hindex of 25, co-authored 114 publications receiving 2044 citations. Previous affiliations of Shigeo Nakamura include Seikei University & Kyushu University.

Papers
More filters
Journal ArticleDOI

Comparison of capsule endoscopy and enteroscopy with the double-balloon method in patients with obscure bleeding and polyposis.

TL;DR: DBE appears to be superior to CE in the diagnosis of small-intestinal polyps, whereas the value for diagnosing gastrointestinal bleeding of obscure origin is similar in the two procedures.
Journal ArticleDOI

Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.

TL;DR: The amino acid-type fullerene derivative was the most efficient in human immunodeficiency virus-reverse transcriptase inhibition of hepatitis C virus RNA-dependent RNA polymerase inhibition.
Journal ArticleDOI

Physical properties and structure of silk. VI. Conformational changes in silk fibroin induced by immersion in water at 2 to 130°c

TL;DR: In this article, the random-coil and β-form conformations were immersed in water at temperatures from 2 to 130°C, and conformational changes were followed by x-ray diffraction, infrared spectroscopy and differential scanning calorimetry.
Journal Article

B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis.

TL;DR: The results suggest that H. pylori is more closely associated with the precursor or initial phase in the genesis of gastric MALT lymphoma than with the later phase, as its density decreases as the tumor progresses.
Journal ArticleDOI

Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection.

TL;DR: Larger SECs are associated with a higher risk of local recurrence after EMR, and in patients with residual lesions, coagulation therapy does not seem to be adequate as additional endoscopic treatment.